logo

For the Inventor, By the Inventor

Chicago, IL, United States of America

Wendy Lee

This inventor holds 10 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Merck + Co., Inc., Other. Active years: 1994-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy Lee. Retrieved from https://idiyas.com/inventor/wendy-lee-v47yxknh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 106(Granted Patents)


Location History:

  • Chicago, IL (US) (1994 - 1996)
  • Hamden, CT (US) (1998 - 2001)

Company Filing History:

goldMedal7 out of 4,189 
 
Abbott Laboratories Corporation
 patents
silverMedal2 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal1 out of 834,570 
Other
 patents

Years Active: 1994-2001

Loading Chart...
10 patents (USPTO):Explore Patents
1. 6187799 - Inhibition of raf kinase activity using aryl ureas (2001-02-13),
2. 5840758 - Oxime derivatives of fenamates as inhibitors of prostaglandin (1998-11-24),
3. 5750558 - Oxime derivatives of indole and indene compounds as inhibitors of (1998-05-12),
4. 5484786 - Pyran-4-ylmethyl substituted arylalkylaryl-, arylalkenylylaryl-, and (1996-01-16),
5. 5446062 - ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and (1995-08-29),
6. 5432194 - (4-alkoxypyran-4-yl) substituted arylalkylaryl-, aryalkenylaryl-, and (1995-07-11),
7. 5407959 - (Trans-1,4-dialkoxycyclohexyl) substituted (1995-04-18),
8. 5346914 - (4-alkoxypyran-4-yl) substituted arylalkylaryl-, arylalkenylaryl-, and (1994-09-13),
9. 5336674 - 2-phenanthridinyl carbaphenem antibacterial agent (1994-08-09),
10. 5328904 - 2-phenanthridinyl carbapenem antibacterial agents (1994-07-12),

Title: The Innovative Contributions of Wendy Lee

Introduction

Wendy Lee is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of pharmaceuticals. With a total of 10 patents to her name, she has made remarkable advancements in the treatment of various medical conditions.

Latest Patents

Wendy's latest patents include groundbreaking work on the inhibition of raf kinase activity using aryl ureas. This method focuses on treating tumors mediated by raf kinase with substituted urea compounds. Additionally, she has developed oxime derivatives of fenamates as inhibitors of prostaglandin biosynthesis. These compounds are designed to treat inflammatory disease states effectively.

Career Highlights

Throughout her career, Wendy has worked with renowned companies such as Abbott Laboratories Corporation and Merck & Company, Inc. Her experience in these leading organizations has allowed her to refine her skills and contribute to innovative solutions in the pharmaceutical industry.

Collaborations

Wendy has collaborated with notable professionals in her field, including Joseph F. Dellaria, Jr. and Anwer Basha. These partnerships have further enhanced her research and development efforts.

Conclusion

Wendy Lee's innovative work and dedication to advancing medical treatments through her patents have made her a significant figure in the pharmaceutical industry. Her contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…